Casodex

Casodex Indications/Uses

bicalutamide

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
50-mg: Treatment of advanced prostate cancer in combination with luteinizing hormone-releasing hormone (LHRH) analogue therapy or surgical castration.
150-mg: Casodex 150 mg is indicated either alone or as adjuvant to radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer at high risk for disease progression (see Pharmacology: Pharmacodynamics under Actions).
Casodex 150 mg is also indicated for the management of patients with locally advanced, non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in